Dr. Thomas C. Blevins, M.D.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
6500 North Mo Pac Expressway, Building 3, Suite 200
Austin, TX 78731
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 838
Licensed in Texas since 1981, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: Baylor College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TX license F9214 (first issued 1981; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- North Austin Medical Center Austin, TX
- Ascension Seton Highland Lakes Burnet, TX
Medical groups
- Texas Diabetes and Endocrinology, P.a. (26 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 838
- Services billed
- 11,289
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,492 | 836 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 302 | 145 |
| Injection of drug or substance under skin or into muscle | 108 | 22 |
| Ultrasound scan of head and neck soft tissue | 82 | 80 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Austin, TX | 1,381 |
| Ezetimibe Other prescribers in Austin, TX | 853 |
| Rosuvastatin Calcium Other prescribers in Austin, TX | 757 |
| Synthroid (levothyroxine sodium) Other prescribers in Austin, TX | 679 |
| Atorvastatin Calcium Other prescribers in Austin, TX | 614 |
| Mounjaro (tirzepatide) Other prescribers in Austin, TX | 393 |
| Alendronate Sodium Other prescribers in Austin, TX | 376 |
| Ozempic (semaglutide) Other prescribers in Austin, TX | 353 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Austin, TX | 344 |
| Jardiance (empagliflozin) Other prescribers in Austin, TX | 273 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 28 companies reported 185 payments worth $120,579 in total to this clinician.
| Sanofi-aventis U.S. LLC | $38,077 |
|---|---|
| Lilly USA, LLC | $29,574 |
| Tandem Diabetes Care, Inc. | $20,208 |
| Mannkind Corporation | $8,906 |
| Eli Lilly and Company | $8,167 |
| Dexcom, Inc. | $5,939 |
| Novo Nordisk Inc | $4,343 |
| Corcept Therapeutics | $2,508 |
| Compensation for services other than consulting (speaking, faculty) | $81,990 |
|---|---|
| Consulting Fee | $13,260 |
| Travel and Lodging | $8,736 |
| Honoraria | $8,075 |
| Speaking at a medical education program | $5,745 |
| Food and Beverage | $2,723 |
| Education | $50.10 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $7,740 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Sanofi-aventis U.S. LLC Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $5,483 |
| Sanofi-aventis U.S. LLC Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $5,483 |
| Mannkind Corporation Apr 25, 2025 | Honoraria AFREZZA · DIABETES MEDICINE | $5,206 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $4,500 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $3,600 |
| Lilly USA, LLC Nov 20, 2025 | Consulting Fee MOUNJARO · Diabetes | $3,600 |
| Dexcom, Inc. Feb 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $3,447 |
All 104 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $2,293 |
| Corcept Therapeutics Dec 17, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Austin, TX | $33.00 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $4,500 |
| Eli Lilly and Company Dec 12, 2025 | Consulting Fee | $1,575 |
| Eli Lilly and Company Dec 12, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN | $54.41 |
| Eli Lilly and Company Dec 12, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN | $35.00 |
| Eli Lilly and Company Dec 12, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN | $31.50 |
| Amgen Inc. Dec 8, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $10.02 |
| Convatec Inc. Dec 4, 2025 | Consulting Fee | $1,160 |
| Eli Lilly and Company Dec 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, TX · in-kind | $379 |
| Eli Lilly and Company Dec 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $209 |
| Eli Lilly and Company Dec 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, TX · in-kind | $130 |
| Lilly USA, LLC Dec 2, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ARLINGTON, TX | $35.00 |
| Lilly USA, LLC Dec 2, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ARLINGTON, TX | $31.50 |
| Amgen Inc. Dec 1, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $10.02 |
| Lilly USA, LLC Nov 20, 2025 | Consulting Fee MOUNJARO · Diabetes | $3,600 |
| Lilly USA, LLC Nov 20, 2025 | Consulting Fee MOUNJARO · Diabetes | $1,575 |
| Lilly USA, LLC Nov 13, 2025 | Travel and Lodging travel to ARLINGTON, TX · in-kind | $519 |
| Amgen Inc. Nov 10, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $10.02 |
| Tandem Diabetes Care, Inc. Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $1,250 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $494 |
| Mannkind Corporation Sep 27, 2025 | Honoraria AFREZZA · DIABETES MEDICINE | $2,869 |
| Mannkind Corporation Sep 27, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to DALLAS, TX | $10.50 |
| Mannkind Corporation Sep 27, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to DALLAS, TX | $10.50 |
| Amgen Inc. Sep 22, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $10.02 |
| Lilly USA, LLC Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Tandem Diabetes Care, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $3,250 |
| Tandem Diabetes Care, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $195 |
| Amgen Inc. Aug 21, 2025 | Education TEPEZZA · Inflammation/Rare Disease · in-kind | $10.02 |
| Tandem Diabetes Care, Inc. Aug 14, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to Houston, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $174 |
| Tandem Diabetes Care, Inc. Aug 14, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to Houston, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $144 |
| Eli Lilly and Company Aug 6, 2025 | Travel and Lodging travel to CHICAGO, IL Company’s descriptionTRAVEL EXPENSES RELATED TO PROVIDING RESEARCH RELATED SERVICES | $690 |
| Eli Lilly and Company Aug 6, 2025 | Travel and Lodging travel to CHICAGO, IL Company’s descriptionTRAVEL EXPENSES RELATED TO PROVIDING RESEARCH RELATED SERVICES | $120 |
| Tandem Diabetes Care, Inc. Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $3,250 |
| Tandem Diabetes Care, Inc. Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $56.00 |
| Novo Nordisk Inc Jul 21, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $1,163 |
| Lilly USA, LLC Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,800 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $675 |
| Lilly USA, LLC Jun 24, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to BASTROP, TX | $59.50 |
| Lilly USA, LLC Jun 24, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to BASTROP, TX | $3.94 |
| Eli Lilly and Company Jun 22, 2025 | Travel and Lodging travel to CHICAGO, TX · in-kind | $432 |
| Lilly USA, LLC Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Tandem Diabetes Care, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $3,250 |
| Tandem Diabetes Care, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $3,250 |
| Tandem Diabetes Care, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $196 |
| Tandem Diabetes Care, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $66.00 |
| Lilly USA, LLC Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,800 |
| Lilly USA, LLC Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,125 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Fort Worth, TX · in-kind | $600 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Fort Worth, TX · in-kind | $339 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Fort Worth, TX | $35.00 |
| Sanofi-aventis U.S. LLC Jun 12, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Fort Worth, TX | $31.50 |
| Tandem Diabetes Care, Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $1,250 |
| Tandem Diabetes Care, Inc. Jun 10, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to Dallas, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $275 |
| Sanofi-aventis U.S. LLC Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $5,483 |
| Sanofi-aventis U.S. LLC Jun 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to San Antonio, TX | $133 |
| Sanofi-aventis U.S. LLC Jun 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to San Antonio, TX | $54.02 |
| Tandem Diabetes Care, Inc. Jun 4, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to The Woodlands, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $747 |
| Tandem Diabetes Care, Inc. Jun 4, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to The Woodlands, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $392 |
| Tandem Diabetes Care, Inc. Jun 4, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to The Woodlands, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $32.61 |
| Tandem Diabetes Care, Inc. Jun 4, 2025 | Travel and Lodging t:slim X2 Insulin Pump with Control-IQ · Endocrinology · travel to The Woodlands, TX · in-kind Company’s descriptionAPEX Speakers Bureau | $16.30 |
| Lilly USA, LLC May 23, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to AUSTIN, TX | $7.00 |
| Dexcom, Inc. May 19, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $2,298 |
| Lilly USA, LLC May 19, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,800 |
| Lilly USA, LLC May 19, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $675 |
| Lilly USA, LLC May 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Mannkind Corporation Apr 25, 2025 | Honoraria AFREZZA · DIABETES MEDICINE | $5,206 |
| Mannkind Corporation Apr 25, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to CHICAGO, IL | $195 |
| Mannkind Corporation Apr 25, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to CHICAGO, IL | $29.48 |
| Mannkind Corporation Apr 25, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to CHICAGO, IL | $28.00 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Lilly USA, LLC Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Houston, TX · in-kind | $304 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Houston, TX · in-kind | $187 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Houston, TX | $32.00 |
| Sanofi-aventis U.S. LLC Apr 11, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Houston, TX | $31.50 |
| Lilly USA, LLC Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,800 |
| Lilly USA, LLC Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $675 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,800 |
| Novo Nordisk Inc Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $2,569 |
| Tandem Diabetes Care, Inc. Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) t:slim X2 Insulin Pump with Control-IQ · Endocrinology · in-kind Company’s descriptionAPEX Speakers Bureau | $2,000 |
| Lilly USA, LLC Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $7,740 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ · in-kind | $576 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ · in-kind | $426 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ | $56.00 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ | $30.80 |
| Lilly USA, LLC Mar 4, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to DENVER, CO | $46.00 |
| Lilly USA, LLC Mar 4, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to DENVER, CO | $31.50 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $3,600 |
| Medtronic, Inc. Feb 27, 2025 | Consulting Fee MINIMED 770G · Durable Pump | $850 |
| Lilly USA, LLC Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Lilly USA, LLC Feb 21, 2025 | Travel and Lodging travel to DENVER, CO · in-kind | $272 |
| Lilly USA, LLC Feb 21, 2025 | Travel and Lodging travel to DENVER, TX · in-kind | $107 |
| Mannkind Corporation Feb 14, 2025 | Travel and Lodging AFREZZA · DIABETES MEDICINE · travel to CHICAGO, IL | $407 |
| Lilly USA, LLC Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $900 |
| Sanofi-aventis U.S. LLC Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $5,483 |
| Sanofi-aventis U.S. LLC Feb 11, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Waco, TX | $133 |
| Dexcom, Inc. Feb 5, 2025 | Speaking at a medical education program DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology | $3,447 |
| Sanofi-aventis U.S. LLC Feb 5, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $2,258 |
| Dexcom, Inc. Jan 30, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX | $63.87 |
| Dexcom, Inc. Jan 30, 2025 | Travel and Lodging DEXCOM G7 GSS (161); DEXCOM STELO GLUCOSE BIOSENSOR · Endocrinology · travel to Austin, TX | $14.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 18 industry-funded studies in 2025, from 9 companies. The companies reported $1,185,797 in research payments for these studies, mostly to the institutions running them.
- Innovative Automated Insulin Delivery System for Type 2 Diabetes
Sequel Med Tech, LLC · Completed · NCT06853990 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly and Company · Active, not recruiting · NCT05869903 - A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity without type 2 diabetes
Boehringer Ingelheim Pharmaceuticals, Inc. - A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of tirzepatide once weekly compared to placebo in adult participants with type 1 diabetes a…
Eli Lilly and Company - Evaluation of the dexcom continuous glucose monitoring (cgm) system survivability and data delivery reliability in adults and pediatrics with type 1 and type 2 diabetes
Dexcom, Inc. - Multi-session evaluation of the investigational dexcom continuous glucose monitoring (cgm) system in adult participants
Dexcom, Inc. - Study name not reported
Novo Nordisk As - M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Eli Lilly and Company · Completed · NCT05882045
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.